Who owns Ariad Pharmaceuticals?

Top Holders and Investors of ARIA Stock

Find out what company owns Ariad Pharmaceuticals, who bought ARIA this quarter, and who sold shares of ARIA stock?

Fund or Company Name Number of Shares Valued At As Of
BlackRock Fund Advisors 8.96M $111.46M Dec 2016
BlackRock Institutional Trust Company, N.A. 4.86M $60.49M Dec 2016
FNY Partners Fund 1.43M $34.30M Mar 2017
BlackRock Investment Management 667499 $8.30M Dec 2016
BlackRock Advisors 196087 $2.44M Dec 2016
E E Geduld 190900 $2.37M Dec 2016
BlackRock 166008 $2.07M Dec 2016
Cupps Capital Management 88235 $1.21M Sep 2016
EverPoint Asset Management 45000 $559800 Dec 2016
Emerald Acquisition 39056 $534676 Sep 2016
BlackRock 16920 $210654 Dec 2016
Metlife Securities 13088 $142790 Dec 2016
BlackRock Japan 1769 $22006 Dec 2016

Who sold Ariad Pharmaceuticals?

Fund Name Date Sold Shares Held Valued At
Two Sigma Investments Dec. 31, 2016 1.83M $22.82M
Morgan Stanley Dec. 31, 2016 1.08M $13.39M
Tamarack Advisers Dec. 31, 2016 850000 $10.57M
Two Sigma Advisers Dec. 31, 2016 568749 $7.08M
Nationwide Fund Advisors Dec. 31, 2016 168431 $2.10M
Landscape Capital Management Dec. 31, 2016 81003 $1.01M
Bank of America Corporation Dec. 31, 2016 67923 $845641
AH Lisanti Capital Growth Dec. 31, 2016 65750 $817930
Royal Bank of Canada Dec. 31, 2016 47187 $584646
CONCERT Wealth Management Dec. 31, 2016 40399 $500139
Tiaa Cref Trust Co Fsb/mo Dec. 31, 2016 30000 $372900
Two Sigma Securities Dec. 31, 2016 15539 $192994
FineMark National Bank & Trust Dec. 31, 2016 800 $10000
Northwestern Mutual Wealth Management Company Dec. 31, 2016 500 $6000
D.A. Davidson & Co. Dec. 31, 2016 400 $4000